Journal article icon

Journal article

Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.

Abstract:

BACKGROUND: Campath 1H is a depleting, humanized anti-CD52 monoclonal antibody that has now been used in 31 renal allograft recipients. The results have been very encouraging and are presented herein. METHODS: Campath 1H was administered, intravenously, in a dose of 20 mg, on day 0 and day 1 after renal transplant. Low-dose cyclosporine (Neoral) was then initiated at 72 hr after transplant. These patients were maintained on low-dose monotherapy with cyclosporine. RESULTS: At present, the mea...

Expand abstract

Actions


Access Document


Authors


Expand authors...
Journal:
Transplantation
Volume:
68
Issue:
10
Pages:
1613-1616
Publication date:
1999-11-05
DOI:
EISSN:
1534-6080
ISSN:
0041-1337
URN:
uuid:bb1f10a8-7f29-4d4c-9fa2-1b5ff99e140e
Source identifiers:
26673
Local pid:
pubs:26673

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP